Last updated: January 23, 2024
Sponsor: University of Chicago
Overall Status: Completed
Phase
1
Condition
N/ATreatment
Placebo
Methamphetamine
Clinical Study ID
NCT05003076
IRB21-0769
Ages 18-35 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: BMI between 19 and 26 Less than 4 alcohol or caffeinated beverages a day.
Exclusion
Exclusion Criteria: High blood pressure Any medical condition requiring regular medication Individuals with a current (within thelast year) DSM-IV Axis 1 diagnosis Individuals with a history of dependence on stimulantdrugs Women who are pregnant or trying to become pregnant.
Study Design
Total Participants: 40
Treatment Group(s): 2
Primary Treatment: Placebo
Phase: 1
Study Start date:
July 01, 2021
Estimated Completion Date:
April 01, 2023
Connect with a study center
University of Chicago
Chicago, Illinois 60637
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.